Manufacturer
Rigel Pharmaceuticals
- Products listed
- 6
- Molecules
- 4
- Therapy areas
- 2
Rigel Pharmaceuticals is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 6 of its products across 4 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Rigel Pharmaceuticals, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Rigel Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Haematology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Tavalisse 100 mg tabletOral | Fostamatinib | US FDA | Available on request |
| Tavalisse 150 mg tabletOral | Fostamatinib | US FDA | Available on request |
Oncology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Gavreto 100 mg capsuleOral | Pralsetinib | US FDA | Available on request |
Other products
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Rezlidhia 150 mg capsuleOral | Olutasidenib | US FDA | Available on request |
| Veppanu 100 mg tabletOral | Vepdegestrant | US FDA | Available on request |
| Veppanu 200 mg tabletOral | Vepdegestrant | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Rigel Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.